KIA
CNCE

Kraematon Investment Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Kraematon Investment Advisors’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,535
Closed -$14.8K – 273
2022
Q4 		$14.8K Buy
+2,535
New +$14.8K 0.02% 184